Biotech research

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Biotech Stocks

Here’s What’s Moving Novartis AG (ADR) (NYSE:NVS) and Kamada Ltd (NASDAQ:KMDA)

Xenon Pharmaceuticals (XENE) Just Took A Hit: Here’s Why And What’s Next

GlaxoSmithKline plc (ADR) (NYSE:GSK) Presents Positive Data From Phase III Shingles Vaccine

Aetna Inc (NYSE:AET) Strikes Diabetes Deal With Medtronic (NYSE:MDT)

GlaxoSmithKline plc (ADR) (NYSE:GSK) To Receive $235M From Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) As Part Of Coreg Patent Trial

Novartis AG (ADR) (NYSE:NVS) Closing In On Kisqali Approval In Europe

AbbVieInc (NYSE:ABBV) Launches Phase 3 Clinical Trial For VENCLEXTA For Multiple...

Weekly Biotech Report Covering Advanced Accelerator Application SA (ADR) (NASDAQ:AAAP)

Cellectis SA (ADR) (NASDAQ:CLLS) Just Made A Big Step Forward In...

Mazor Robotics Ltd – ADR (NASDAQ:MZOR) Obtains An FDA Nod For...

Market Exclusive Weekly Biotech Report Covering Gilead Sciences, Inc. (NASDAQ:GILD) and...

Sanofi SA (ADR) (NYSE:SNY) To Invest More In Biologics Manufacturing Network

Is the Advanced Accelerator Application SA (ADR) (NASDAQ:AAAP) Delay Cause for...

European Commission Clears Novartis AG (ADR) (NYSE:NVS) Blood Cancer Drug

Biotech Movers: Egalet Corporation (NASDAQ:EGLT) and Neos Therapeutics, Inc. (NASDAQ:NEOS)

EDITOR PICKS

Xenon Pharmaceuticals (XENE) Just Took A Hit: Here’s Why And What’s...

Here’s Why These Two Biotechnology Companies Took A Hit On Monday:...

Here’s What Just Happened With Portola Pharmaceuticals Inc (NASDAQ:PTLA) and bluebird...

POPULAR POSTS

Vistagen Therapeutics Is A $17M Company With a Potentially $2.8B Drug

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

POPULAR CATEGORY